MRVI — Maravai Lifesciences Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Maravai Lifesciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	24.7	236	551	632	575
Net Total Accounts Receivable
Net Total Receivables	18.8	51.2	118	147	55.7
Total Inventory
Prepaid Expenses
Total Current Assets	60.6	332	740	848	700
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	94.3	101	95.4	117	223
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	578	1,271	1,918	2,282	1,487
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	29.6	131	93.8	110	87.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	436	1,182	1,603	1,737	1,071
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	141	88.5	315	545	417
Total Liabilities & Shareholders' Equity	578	1,271	1,918	2,282	1,487
Total Common Shares Outstanding